Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

PubWeight™: 2.67‹?› | Rank: Top 1%

🔗 View Article (PMID 23649443)

Published in Chest on May 01, 2013

Authors

John A Howington1, Matthew G Blum, Andrew C Chang, Alex A Balekian, Sudish C Murthy

Author Affiliations

1: NorthShore University Health System, University of Chicago Pritzker School of Medicine, 2650 Ridge Ave, 3507 Walgreen Bldg, Evanston, IL 60201, USA. jhowington@northshore.org

Associated clinical trials:

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC | NCT04730453

Articles citing this

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83

Audit of lymphadenectomy in lung cancer resections using a specimen collection kit and checklist. Ann Thorac Surg (2014) 2.08

Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity? J Thorac Cardiovasc Surg (2016) 2.03

Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease. Ann Am Thorac Soc (2015) 1.40

LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective. Br J Radiol (2015) 1.38

Lung cancer: Biology and treatment options. Biochim Biophys Acta (2015) 1.02

The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest (2014) 1.00

Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res (2016) 0.99

Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer. Ann Cardiothorac Surg (2014) 0.97

Checkpoint inhibitors in lung cancer: latest developments and clinical potential. Ther Adv Med Oncol (2016) 0.96

Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review. Onco Targets Ther (2015) 0.95

Opportunities to address lung cancer disparities among African Americans. Cancer Med (2014) 0.92

The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention. Transl Lung Cancer Res (2015) 0.91

Radiofrequency ablation for early-stage nonsmall cell lung cancer. Biomed Res Int (2014) 0.91

Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care (2014) 0.90

Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art. Transl Lung Cancer Res (2015) 0.87

A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Thorac Oncol (2014) 0.87

Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller. Int J Clin Oncol (2014) 0.86

Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections. Mod Pathol (2015) 0.85

Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma. Sci Rep (2015) 0.84

The expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohorts. Cancer Epidemiol Biomarkers Prev (2014) 0.84

Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC). Surg Today (2015) 0.84

Complex uniportal video-assisted thoracoscopic sleeve lobectomy during live surgery broadcasting. J Thorac Dis (2016) 0.83

Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer. Cancer Control (2016) 0.82

Reasons not to perform uniportal VATS lobectomy. J Thorac Dis (2016) 0.81

Home-based exercise: promising rehabilitation for symptom relief, improved functional status and quality of life for post-surgical lung cancer patients. J Thorac Dis (2014) 0.81

Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget (2016) 0.81

Video-Assisted versus Open Lobectomy in Patients with Compromised Lung Function: A Literature Review and Meta-Analysis. PLoS One (2015) 0.80

Feasibility of transumbilical anatomic pulmonary lobectomy in a canine model. Surg Endosc (2014) 0.80

Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients. Clin Lung Cancer (2015) 0.80

Survival analyses of postoperative lung cancer patients: an investigation using Japanese administrative data. Springerplus (2014) 0.80

Comparison of treatment outcomes between single-port video-assisted thoracoscopic anatomic segmentectomy and lobectomy for non-small cell lung cancer of early-stage: a retrospective observational study. J Thorac Dis (2016) 0.80

Update in Lung Cancer 2014. Am J Respir Crit Care Med (2015) 0.79

Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients. World J Surg Oncol (2014) 0.79

Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer. Medicine (Baltimore) (2015) 0.79

The Utility of Exercise Testing in Patients with Lung Cancer. J Thorac Oncol (2016) 0.78

REDOX IMBALANCE IN LUNG CANCER OF PATIENTS WITH UNDERLYING CHRONIC RESPIRATORY CONDITIONS. Mol Med (2016) 0.78

PD-1/PD-L1 blockades in non-small-cell lung cancer therapy. Onco Targets Ther (2016) 0.78

Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery. Cancer Imaging (2016) 0.78

Selection for adjuvant chemotherapy in completely resected stage I non-small cell lung cancer: external validation of a Chinese prognostic risk model. J Thorac Dis (2016) 0.78

Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma. Oncol Rev (2014) 0.77

Pre-operative localization of solitary pulmonary nodules with computed tomography-guided hook wire: report of 181 patients. J Cardiothorac Surg (2016) 0.77

Uniportal video-assisted thoracoscopic surgery: safety, efficacy and learning curve during the first 250 cases in Quebec, Canada. Ann Cardiothorac Surg (2016) 0.77

Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: When and Why Is It Appropriate Therapy? J Adv Pract Oncol (2015) 0.77

Surgical strategies in the therapy of non-small cell lung cancer. World J Clin Oncol (2014) 0.77

Minimally invasive surgical techniques are safe in the diagnosis and treatment of pediatric malignancies. Surg Endosc (2014) 0.77

From anatomy to lung cancer: questioning lobe-specific mediastinal lymphadenectomy reliability. J Thorac Dis (2016) 0.77

Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC. Onco Targets Ther (2015) 0.77

C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool: an observational study. Medicine (Baltimore) (2015) 0.76

Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer. Radiat Oncol (2016) 0.76

Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know. Indian J Radiol Imaging (2016) 0.76

Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer. Thorac Cancer (2014) 0.76

Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care. Heart Lung Vessel (2014) 0.76

Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer. Oncologist (2015) 0.75

Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria. Ann Thorac Surg (2017) 0.75

Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC. J Thorac Oncol (2016) 0.75

Prospective evaluation of anxiety, depression and quality of life in medically inoperable early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy. Rep Pract Oncol Radiother (2017) 0.75

Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study. Medicine (Baltimore) (2016) 0.75

VATS lobectomy program: the trainee perspective. J Thorac Dis (2016) 0.75

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer. Ann Thorac Surg (2016) 0.75

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival. Ann Thorac Surg (2016) 0.75

Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs. Transl Lung Cancer Res (2015) 0.75

Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal. Thorac Cancer (2015) 0.75

Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer? Ann Transl Med (2015) 0.75

Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population. PLoS One (2016) 0.75

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines. BMC Cancer (2014) 0.75

Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study. PLoS One (2015) 0.75

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC. EJNMMI Res (2017) 0.75

Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial. PLoS One (2016) 0.75

Does an extended mediastinal lymphadenectomy improve outcome after R0 resection in lung cancer? Chin J Cancer Res (2014) 0.75

Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules. Medicine (Baltimore) (2015) 0.75

Sublobar resection is associated with improved outcomes over radiotherapy in the management of high-risk elderly patients with Stage I non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget (2017) 0.75

Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery. Nagoya J Med Sci (2017) 0.75

Shared decision making in the treatment of stage I non small cell lung cancer-a choice which should equally involve both sides. Ann Transl Med (2017) 0.75

Anatomic lung resections for benign pulmonary diseases by video-assisted thoracoscopic surgery (VATS). Langenbecks Arch Surg (2016) 0.75

Exercise training for people following curative intent treatment for non-small cell lung cancer: a randomized controlled trial. Braz J Phys Ther (2017) 0.75

Feasibility and Safety of Single-Port Video-Assisted Thoracic Surgery for Primary Lung Cancer. Korean J Thorac Cardiovasc Surg (2017) 0.75

Video-assisted thoracoscopic surgery node dissection for lung cancer treatment. Surg Today (2017) 0.75

Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma. World J Surg (2017) 0.75

Medicoeconomic analysis of lobectomy using thoracoscopy versus thoracotomy for lung cancer: a study protocol for a multicentre randomised controlled trial (Lungsco01). BMJ Open (2017) 0.75

Video-assisted thoracoscopic anatomic lung resections in Germany-a nationwide survey. Langenbecks Arch Surg (2016) 0.75

Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective study. J Thorac Dis (2017) 0.75

Articles by these authors

(truncated to the top 100)

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med (2008) 10.12

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.02

Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93

International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg (2015) 2.61

Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw (2013) 2.56

Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg (2007) 2.48

Non-small cell lung cancer. J Natl Compr Canc Netw (2012) 2.40

Refining esophageal cancer staging. J Thorac Cardiovasc Surg (2003) 2.18

Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 2.16

KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma. J Thorac Oncol (2014) 1.99

Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Mod Pathol (2006) 1.87

Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer. J Clin Oncol (2009) 1.79

A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg (2008) 1.69

A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma. Am J Clin Pathol (2009) 1.59

Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.57

Management of congenital and acquired pulmonary vein stenosis. Ann Thorac Surg (2006) 1.50

Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann Thorac Surg (2006) 1.43

Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J (2012) 1.43

A physiologic clinical study of achalasia: should Dor fundoplication be added to Heller myotomy? J Thorac Cardiovasc Surg (2005) 1.42

Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.41

Standardisation of von Willebrand Factor in therapeutic concentrates: calibration of the 1st International Standard for von Willebrand Factor concentrate (00/514). Thromb Haemost (2002) 1.40

T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg (2007) 1.38

CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys (2005) 1.38

Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis. J Thorac Oncol (2011) 1.32

Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. Neoplasia (2006) 1.28

Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg (2010) 1.27

Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res (2007) 1.26

Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg (2009) 1.25

Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg (2005) 1.25

Bridge to lung transplantation using short-term ambulatory extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg (2010) 1.21

Characterization and importance of air leak after lobectomy. Ann Thorac Surg (2005) 1.19

The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg (2009) 1.14

Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proc Natl Acad Sci U S A (2012) 1.12

Surgical treatment of epiphrenic diverticula: a 30-year experience. Ann Thorac Surg (2007) 1.09

Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res (2010) 1.07

Lungs from donation after cardiac death for transplantation. Eur J Cardiothorac Surg (2013) 1.07

Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol (2010) 1.06

Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 1.06

Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: risk factors, presentation, and detection. Ann Thorac Surg (2009) 1.05

Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol (2009) 1.05

Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature. Am J Clin Pathol (2009) 1.05

Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy? Ann Thorac Surg (2006) 1.04

Transhiatal esophagectomy in the profoundly obese: implications and experience. Ann Thorac Surg (2007) 1.03

Spirometry after transplantation: how much better are two lungs than one? Ann Thorac Surg (2008) 1.03

Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg (2005) 1.02

Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg (2008) 1.02

Multifocal presentation of gangliocytic paraganglioma in the mediastinum and esophagus. Hum Pathol (2004) 1.02

Malignant pleural mesothelioma. Curr Oncol Rep (2011) 1.01

Environmental risks of trace elements associated with long-term phosphate fertilizers applications: a review. Environ Pollut (2012) 1.01

Guidelines for donor lung selection: time for revision? Ann Thorac Surg (2010) 1.01

Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia (2009) 1.00

Lung transplantation for idiopathic pulmonary fibrosis. Ann Thorac Surg (2007) 1.00

Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma. Clin Cancer Res (2013) 0.99

Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg (2013) 0.98

Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg (2007) 0.96

Impact of long-term reclaimed wastewater irrigation on agricultural soils: a preliminary assessment. J Hazard Mater (2010) 0.96

Soil enzyme activities of long-term reclaimed wastewater-irrigated soils. J Environ Qual (2008) 0.95

Polyflex expandable stents in the treatment of esophageal disease: initial experience. Ann Thorac Surg (2008) 0.94

Performance of a self-expanding silicone stent in palliation of benign airway conditions. Chest (2006) 0.94

AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. J Thorac Oncol (2008) 0.94

Lung lesion doubling times: values and variability based on method of volume determination. Clin Radiol (2007) 0.94

Combined bronchoscopy, mediastinoscopy, and thoracotomy for lung cancer: who benefits? J Thorac Cardiovasc Surg (2004) 0.92

Matching donor to recipient in lung transplantation: How much does size matter? J Thorac Cardiovasc Surg (2009) 0.92

Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg (2006) 0.92

Dialysis after lung transplantation: prevalence, risk factors and outcome. J Heart Lung Transplant (2007) 0.92

Esophageal cancer in patients with a history of distal gastrectomy. Arch Surg (2002) 0.92

Myenteric plexus abnormalities associated with epiphrenic diverticula. Eur J Cardiothorac Surg (2008) 0.92

Techniques of surgical tracheostomy. Clin Chest Med (2003) 0.91

A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer. J Thorac Oncol (2010) 0.91

Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant (2008) 0.90

Growing single-center experience with lung transplantation using donation after cardiac death. Ann Thorac Surg (2012) 0.90

Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys (2009) 0.90

Arsenic, cadmium, and lead in California cropland soils: role of phosphate and micronutrient fertilizers. J Environ Qual (2008) 0.90

Esophageal submucosa: the watershed for esophageal cancer. J Thorac Cardiovasc Surg (2011) 0.89

Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping. Mol Cell Proteomics (2006) 0.89

The Kirschner operation in unresectable esophageal cancer: current application. Arch Surg (2002) 0.89

Degradation and adsorption of selected pharmaceuticals and personal care products (PPCPs) in agricultural soils. Chemosphere (2009) 0.89

Retrograde gastric intussusception after myotomy for achalasia. Ann Thorac Surg (2006) 0.89

Intraoperative and postoperative management of air leaks in patients with emphysema. Thorac Surg Clin (2009) 0.89

INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma. J Thorac Oncol (2009) 0.88

[18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: impact of verification bias. Arch Intern Med (2007) 0.87

Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants. Sci Total Environ (2012) 0.86

Diversity of the angiogenic phenotype in non-small cell lung cancer. Am J Respir Cell Mol Biol (2006) 0.84

CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells. Lung Cancer (2013) 0.84

Tension chylothorax. Ann Thorac Surg (2006) 0.84

Stage III non-small cell lung cancer and metachronous brain metastases. J Thorac Cardiovasc Surg (2002) 0.84

Atrial fibrillation after lung transplantation: timing, risk factors, and treatment. Ann Thorac Surg (2007) 0.83

Refractory cervical esophagogastric anastomotic strictures: management and outcomes. J Thorac Cardiovasc Surg (2010) 0.83

Reconstruction of a tracheobronchial tree disruption with bovine pericardium. Interact Cardiovasc Thorac Surg (2004) 0.82

Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg (2008) 0.82

Intramucosal esophageal adenocarcinoma: primum non nocere. J Thorac Cardiovasc Surg (2012) 0.82

Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer. J Thorac Cardiovasc Surg (2003) 0.81

Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma. Genes Chromosomes Cancer (2006) 0.81

Thymic malignancies. J Natl Compr Canc Netw (2010) 0.81

Effect of changes in postoperative spirometry on survival after lung transplantation. J Thorac Cardiovasc Surg (2012) 0.80

Inferior vena cava thrombus removal using hypothermic circulatory arrest in two patients with osteosarcoma. Ann Vasc Surg (2003) 0.80

A root exudates based approach to assess the long-term phytoavailability of metals in biosolids-amended soils. Environ Pollut (2010) 0.80

Uptake of metals by food plants grown on soils 10 years after biosolids application. J Environ Sci Health B (2010) 0.79